Clinical Research Directory
Browse clinical research sites, groups, and studies.
Long-Term Clinical Outcomes Of Subjects Enrolled In The RxSight Light Adjustable Lens (LAL) And Light Delivery Device (LDD) New Enrollment Study
Sponsor: RxSight, Inc.
Summary
This is an observational, follow up study of subjects previously enrolled in the "RxSight Light Adjustable Lens (LAL) and Light Delivery Device (LDD) New Enrollment Study". The primary objective of this study is to collect long-term safety and effectiveness data on RxSight LAL and Control IOL in subjects previously implanted in the "RxSight Light Adjustable Lens (LAL) and Light Delivery Device (LDD) New Enrollment Study".
Key Details
Gender
All
Age Range
Any - Any
Study Type
OBSERVATIONAL
Enrollment
500
Start Date
2025-11-13
Completion Date
2026-09
Last Updated
2026-01-16
Healthy Volunteers
No
Conditions
Interventions
Light Adjustable lens (LAL) and Light Delivery Device (LDD)
Experimental treatment group received Light adjustable lens with Light delivery Device treatments
Control IOL
Control treatment group received a Control IOL
Locations (1)
Focal Point Vision
San Antonio, Texas, United States